Regulon

Regulon: R-3366

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
72.35898110Pr-10Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
3693 ENSG00000082781 ITGB5 P18084
22943 ENSG00000107984 DKK1 O94907
24145 ENSG00000110218 PANX1 A0A024R397
5352 ENSG00000152952 PLOD2 O00469
9903 ENSG00000162413 KLHL21 Q9UJP4
2669 ENSG00000164949 GEM P55040
2650 ENSG00000187210 GCNT1 Q02742

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
CILENGITIDEITGAVProteinANTAGONISTIntegrin alpha-V/beta-3 antagonist33
DKN-01DKK1UnknownINHIBITORDickkopf-related protein 1 inhibitor20
INTETUMUMABITGAVAntibodyANTAGONISTIntegrin alpha-V/beta-3 antagonist20
BHQ-880DKK1AntibodyINHIBITORDickkopf-related protein 1 inhibitor20
ABITUZUMABITGAVAntibodyINHIBITORIntegrin alpha-V/beta-5 inhibitor20

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-3366

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs
CMF-01919PCDH9down-regulatesTEAD4activatesR-336664Drugs (5)

Regulator Drugs (0)

Regulon Drugs (5)

CILENGITIDE, DKN-01, INTETUMUMAB, BHQ-880, ABITUZUMAB

CMF-02047CNGA4up-regulatesTEAD4activatesR-336661Drugs (5)

Regulator Drugs (0)

Regulon Drugs (5)

CILENGITIDE, DKN-01, INTETUMUMAB, BHQ-880, ABITUZUMAB

CMF-07814TNK2down-regulatesTEAD4activatesR-336662Drugs (5)

Regulator Drugs (0)

Regulon Drugs (5)

CILENGITIDE, DKN-01, INTETUMUMAB, BHQ-880, ABITUZUMAB

CMF-08580FOXR2down-regulatesTEAD4activatesR-336663Drugs (5)

Regulator Drugs (0)

Regulon Drugs (5)

CILENGITIDE, DKN-01, INTETUMUMAB, BHQ-880, ABITUZUMAB

CMF-09250RP1down-regulatesTEAD4activatesR-336663Drugs (5)

Regulator Drugs (0)

Regulon Drugs (5)

CILENGITIDE, DKN-01, INTETUMUMAB, BHQ-880, ABITUZUMAB

CMF-14348SIPA1L1down-regulatesTEAD4activatesR-336662Drugs (5)

Regulator Drugs (0)

Regulon Drugs (5)

CILENGITIDE, DKN-01, INTETUMUMAB, BHQ-880, ABITUZUMAB

CMF-16896TIE1up-regulatesTEAD4activatesR-336661Drugs (5)

Regulator Drugs (0)

Regulon Drugs (5)

CILENGITIDE, DKN-01, INTETUMUMAB, BHQ-880, ABITUZUMAB

CMF-20033ARHGEF16down-regulatesTEAD4activatesR-336661Drugs (5)

Regulator Drugs (0)

Regulon Drugs (5)

CILENGITIDE, DKN-01, INTETUMUMAB, BHQ-880, ABITUZUMAB

CMF-30463PROKR2down-regulatesTEAD4activatesR-336663Drugs (5)

Regulator Drugs (0)

Regulon Drugs (5)

CILENGITIDE, DKN-01, INTETUMUMAB, BHQ-880, ABITUZUMAB

CMF-30601SALL4down-regulatesTEAD4activatesR-336662Drugs (5)

Regulator Drugs (0)

Regulon Drugs (5)

CILENGITIDE, DKN-01, INTETUMUMAB, BHQ-880, ABITUZUMAB